Perhaps the distinguishing factor in FTD-MAPT is indeed the presence of tau pathology of genetic origin in all cell types, versus the neuronal and extracellular tau pathology in (non-genetic) AD. The gene discussed is MAPT; the disease is frontotemporal dementia.